The burden of liver diseases is substantial, demanding advanced therapeutic options. Cellular therapies represent a remarkably promising avenue, offering the chance to regenerate damaged hepatic tissue and improve patient outcomes. Currently, research focuses on several approaches, including the introduction of induced pluripotent regenerative unit